Navigating the Complexities of Global Health Initiatives within the Schistosomiasis Disease Market for Sustainable Eradication The Schistosomiasis Disease Market represents a critical sector in tropical medicine, focusing on a parasitic infection that affects over two hundred million people worldwide. This disease, often referred to as snail fever or bilharzia, is caused by parasitic flatworms and is prevalent in tropical and subtropical regions where people lack access to clean water and sanitation. The market is primarily driven by the urgent need for mass drug administration programs and the development of new diagnostic tools to identify infections in asymptomatic carriers. Currently, the landscape is dominated by international health organizations and philanthropic foundations that subsidize the production and distribution of praziquantel, the gold-standard treatment. Ref - https://www.marketresearchfuture.com/reports/schistosomiasis-disease-market-39338